Enhancing shareholder value through exceptional business performance and practices, and through responsible and effective communication with its shareholders.


About Us


Hoth Therapeutics’ research and development activities are focused on creating novel therapies where an unmet medical need exists. Hoth’s innovative pipeline includes The BioLexa Platform, a proprietary, patented antimicrobial therapy being developed for the treatment of Atopic Dermatitis. In addition, the company has other ongoing pre-clinical stage development programs aimed at treating other indications such as asthma, acne, lupus, psoriasis as well as two potential treatments for COVID-19 as well as a medical testing device for COVID-19.